Mannose-binding lectin in innate immunity: Past, present and future

Tissue Antigens

Volumn 68, Issue 3, 2006, Pages 193-209

  Dommett, R M ^a   Klein, N ^a   Turner, M W ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Complement; Disease associations; Innate immunity; Mannose binding lectin (MBL); MBL associated serine proteases (MASPs)

Indexed keywords

CARBOHYDRATE; COLLECTIN; MANNOSE BINDING LECTIN; MANNOSE BINDING LECTIN 2; OLIGOMER; UNCLASSIFIED DRUG;

AUTOIMMUNE DISEASE; BINDING AFFINITY; COMPLEMENT SYSTEM; DEFENSE MECHANISM; EXON; GENE EXPRESSION; GENETIC POLYMORPHISM; HUMAN; HUMORAL IMMUNITY; IMMUNE SYSTEM; INFLAMMATION; INNATE IMMUNITY; NONHUMAN; PHAGOCYTOSIS; POINT MUTATION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW;

COMPLEMENT C1; HUMANS; IMMUNITY, NATURAL; MANNOSE-BINDING LECTIN; POLYMORPHISM, GENETIC;

EID: 33748413638     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2006.00649.x     Document Type: Review

References (153)

1. Burnet FM, McCrea JF. Inhibitory and inactivating action of normal ferret sera against an influenza virus strain. Aust J Exp Biol Med Sci 1946: 24: 277-82.
2. Anders EM, Hartley CA, Jackson DC. Bovine and mouse serum beta inhibitors of influenza A viruses are mannose-binding lectins. Proc Natl Acad Sci U S A 1990: 87: 4485-9.
3. Kawakami M, Ihara I, Suzuki A, Harada Y. Properties of a new complement-dependent bactericidal factor specific for Ra chemotype salmonella in sera of conventional and germ-free mice. J Immunol 1982: 129: 2198-201.
4. Kawakami M, Ihara I, Ihara S, Suzuki A, Fukui K. A group of bactericidal factors conserved by vertebrates for more than 300 million years. J Immunol 1984: 132: 2578-81.
5. Robinson D, Phillips NC, Winchester B. Affinity chromatography of human liver alpha-D-mannosidase. FEBS Lett 1975: 53: 110-2.
6. Kawasaki T, Etoh R, Yamashina I. Isolation and characterization of a mannan-binding protein from rabbit liver. Biochem Biophys Res Commun 1978: 81: 1018-24.
7. Wild J, Robinson D, Winchester B. Isolation of mannose-binding proteins from human and rat liver. Biochem J 1983: 210: 167-74.
8. Seyfarth J, Garred P, Madsen HO. Extra-hepatic transcription of the human mannose-binding lectin gene (mbl2) and the MBL-associated serine protease 1-3 genes. Mol Immunol 2006: 43: 962-71.
9. Holmskov U, Thiel S, Jensenius JC. Collections and ficolins: humoral lectins of the innate immune defense. Annu Rev Immunol 2003: 21: 547-78.
10. Weis WI, Kahn R, Fourme R, Drickamer K, Hendrickson WA. Structure of the calcium-dependent lectin domain from a rat mannose-binding protein determined by MAD phasing. Science 1991: 254: 1608-15.
11. Weis WI, Drickamer K. Trimeric structure of a C-type mannose-binding protein. Structure 1994: 2: 1227-40.
12. Sheriff S, Chang CY, Ezekowitz RA. Human mannose-binding protein carbohydrate recognition domain trimerizes through a triple alpha-helical coiled-coil. Nat Struct Biol 1994: 1: 789-94.
13. Iobst ST, Wormald MR, Weis WI, Dwek RA, Drickamer K. Binding of sugar ligands to Ca(2+)-dependent animal lectins. I. Analysis of mannose binding by site-directed mutagenesis and NMR. J Biol Chem 1994: 269: 15505-11.
14. Palaniyar N, Nadesalingam J, Clark H, Shih MJ, Dodds AW, Reid KB. Nucleic acid is a novel ligand for innate, immune pattern recognition collectins surfactant proteins A and D and mannose-binding lectin. J Biol Chem 2004: 279: 32728-36.
15. Neth O, Jack DL, Dodds AW, Holzel H, Klein NJ, Turner MW. Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition. Infect Immun 2000: 68: 688-93.
16. Jack DL, Dodds AW, Anwar N et al. Activation of complement by mannose-binding lectin on isogenic mutants of Neisseria meningitidis serogroup B. J Immunol 1998: 160: 1346-53.
17. Devyatyarova-Johnson M, Rees IH, Robertson BD, Turner MW, Klein NJ, Jack DL. The lipopolysaccharide structures of Salmonella enterica serovar Typhimurium and Neisseria gonorrhoeae determine the attachment of human mannose-binding lectin to intact organisms. Infect Immun 2000: 68: 3894-9.
18. Ikeda K, Sannoh T, Kawasaki N, Kawasaki T, Yamashina I. Serum lectin with known structure activates complement through the classical pathway. J Biol Chem 1987: 262: 7451-4.
19. Matsushita M, Fujita T. Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease. J Exp Med 1992: 176: 1497-502.
20. Thiel S, Vorup-Jensen T, Stover CM et al. A second serine protease associated with mannan-binding lectin that activates complement. Nature 1997: 386: 506-10.
21. Takahashi M, Endo Y, Fujita T, Matsushita M. A truncated form of mannose-binding lectin-associated serine protease (MASP)-2 expressed by alternative polyadenylation is a component of the lectin complement pathway. Int Immunol 1999: 11: 859-63.
22. Stover CM, Thiel S, Thelen M et al. Two constituents of the initiation complex of the mannan-binding lectin activation pathway of complement are encoded by a single structural gene. J Immunol 1999: 162: 3481-90.
23. Dahl MR, Thiel S, Matsushita M et al. MASP-3 and its association with distinct complexes of the mannan-binding lectin complement activation pathway. Immunity 2001: 15: 127-35.
24. Feinberg H, Uitdehaag JC, Davies JM, Wallis R, Drickamer K, Weis WI. Crystal structure of the CUB1-EGF-CUB2 region of mannose-binding protein associated serine protease-2. EMBO J 2003: 22: 2348-59.
25. Akaiwa M, Yae Y, Sugimoto R et al. Hakata antigen, a new member of the ficolin/opsonin p35 family, is a novel human lectin secreted into bronchus/alveolus and bile. J Histochem Cytochem 1999: 47: 777-86.
26. Liu Y, Endo Y, Iwaki Det al. Human M-ficolin is a secretory protein that activates the lectin complement pathway. J Immunol 2005: 175: 3150-6.
27. Lynch NJ, Roscher S, Hartung T et al. L-ficolin specifically binds to lipoteichoic acid, a cell wall constituent of gram-positive bacteria, and activates the lectin pathway of complement. J Immunol 2004: 172: 1198-202.
28. Miller ME, Seals J, Haye R, Levitsky LC. A familial plasma-associated defect of phagocytosis. Lancet 1968: 2: 60-3.
29. Soothill JF, Harvey BA. Defective opsonization. A common immunity deficiency. Arch Dis Child 1976: 51: 91-9.
30. Candy DC, Larcher VF, Tripp JH, Harries JT, Harvey BA, Soothill JF. Yeast opsonisation in children with chronic diarrhoeal states. Arch Dis Child 1980: 55: 189-93.
31. Turner MW, Mowbray JF, Roberton DR. A study of C3b deposition on yeast surfaces by sera of known opsonic potential. Clin Exp Immunol 1981: 46: 412-9.
32. Super M, Thiel S, Lu J, Levinsky RJ, Turner MW. Association of low levels of mannan-binding protein with a common defect of opsonisation. Lancet 1989: 2: 1236-9.
33. Sastry K, Herman GA, Day L et al. The human mannose-binding protein gene. Exon structure reveals its evolutionary relationship to a human pulmonary surfactant gene and localization to chromosome 10. J Exp Med 1989: 170: 1175-89.
34. Taylor ME, Brickell PM, Craig RK, Summerfield JA. Structure and evolutionary origin of the gene encoding a human serum mannose-binding protein. Biochem J 1989: 262: 763-71.
35. Kuhlman M, Joiner K, Ezekowitz RA. The human mannose-binding protein functions as an opsonin. J Exp Med 1989: 169: 1733-45.
36. Malhotra R, Thiel S, Reid KB, Sim RB. Human leukocyte C1q receptor binds other soluble proteins with collagen domains. J Exp Med 1990: 172: 955-9.
37. Tenner AJ, Robinson SL, Ezekowitz RA. Mannose binding protein (MBP) enhances mononuclear phagocyte function via a receptor that contains the 126,000 M(r) component of the C1q receptor. Immunity 1995: 3: 485-93.
38. Ghiran I, Barbashov SF, Klickstein LB, Tas SW, Jensenius JC, Nicholson-Weller A. Complement receptor 1/CD35 is a receptor for mannan-binding lectin. J Exp Med 2000: 192: 1797-808.
39. Klickstein LB, Barbashov SF, Liu T, Jack RM, Nicholson-Weller A. Complement receptor type 1 (CR1, CD35) is a receptor for C1q. Immunity 1997: 7: 345-55.
40. Soell M, Lett E, Holveck F, Scholler M, Wachsmann D, Klein JP. Activation of human monocytes by streptococcal rhamnose glucose polymers is mediated by CD14 antigen, and mannan binding protein inhibits TNF-alpha release. J Immunol 1995: 154: 851-60.
41. Chaka W, Verheul AF, Vaishnav VV et al. Induction of TNF-alpha in human peripheral blood mononuclear cells by the mannoprotein of Cryptococcus neoformans involves human mannose binding protein. J Immunol 1997: 159: 2979-85.
42. Jack DL, Read RC, Tenner AJ, Frosch M, Turner MW, Klein NJ. Mannose-binding lectin regulates the inflammatory response of human professional phagocytes to Neisseria meningitidis serogroup B. J Infect Dis 2001: 184: 1152-62.
43. Ogden CA, deCathelineau A, Hoffmann PR et al. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J Exp Med 2001: 194: 781-95.
44. Stuart LM, Takahashi K, Shi L, Savill J, Ezekowitz RA. Mannose-binding lectin-deficient mice display defective apoptotic cell clearance but no autoimmune phenotype. J Immunol 2005: 174: 3220-6.
45. Hart ML, Ceonzo KA, Shaffer LA et al. Gastrointestinal ischemia-reperfusion injury is lectin complement pathway dependent without involving C1q. J Immunol 2005: 174: 6373-80.
46. Walsh MC, Bourcier T, Takahashi K et al. Mannose-binding lectin is a regulator of inflammation that accompanies myocardial ischemia and reperfusion injury. J Immunol 2005: 175: 541-6.
47. Hakomori S. Tumor-associated carbohydrate antigens defining tumor malignancy: basis for development of anti-cancer vaccines. Adv Exp Med Biol 2001: 491: 369-402.
48. Ma Y, Uemura K, Oka S, Kozutsumi Y, Kawasaki N, Kawasaki T. Antitumor activity of mannan-binding protein in vivo as revealed by a virus expression system: mannan-binding proteindependent cell-mediated cytotoxicity. Proc Natl Acad Sci U S A 1999: 96: 371-5.
49. Nakagawa T, Kawasaki N, Ma Y, Uemura K, Kawasaki T. Antitumor activity of mannan-binding protein. Methods Enzymol 2003: 363: 26-33.
50. Sumiya M, Super M, Tabona P et al. Molecular basis of opsonic defect in immunodeficient children. Lancet 1991: 337: 1569-70.
51. Lipscombe RJ, Sumiya M, Hill AV et al. High frequencies in African and non-African populations of independent mutations in the mannose binding protein gene. Hum Mol Genet 1992: 1: 709-15.
52. Madsen HO, Garred P, Kurtzhals JA et al. A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein. Immunogenetics 1994: 40: 37-44.
53. Turner MW, Dinan L, Heatley S et al. Restricted polymorphism of the mannose-binding lectin gene of indigenous Australians. Hum Mol Genet 2000: 9: 1481-6.
54. Wallis R, Drickamer K. Molecular determinants of oligomer formation and complement fixation in mannose-binding proteins. J Biol Chem 1999: 274: 3580-9.
55. Madsen HO, Garred P, Thiel S et al. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol 1995: 155: 3013-20.
56. Madsen HO, Satz ML, Hogh B, Svejgaard A, Garred P. Different molecular events result in low protein levels of mannan-binding lectin in populations from southeast Africa and South America. J Immunol 1998: 161: 3169-75.
57. Boldt AB, Petzl-Erler ML. A new strategy for mannosebinding lectin gene haplotyping. Hum Mutat 2002: 19: 296-306.
58. Ezekowitz RA, Day LE, Herman GA. A human mannose-binding protein is an acute-phase reactant that shares sequence homology with other vertebrate lectins. J Exp Med 1988: 167: 1034-46.
59. Thiel S, Holmskov U, Hviid L, Laursen SB, Jensenius JC. The concentration of the C-type lectin, mannan-binding protein, in human plasma increases during an acute phase response. Clin Exp Immunol 1992: 90: 31-5.
60. Mogues T, Ota T, Tauber AI, Sastry KN. Characterization of two mannose-binding protein cDNAs from rhesus monkey (Macaca mulatta): structure and evolutionary implications. Glycobiology 1996: 6: 543-50.
61. Sastry R, Wang JS, Brown DC, Ezekowitz RA, Tauber AI, Sastry KN. Characterization of murine mannose-binding protein genes Mbl1 and Mbl2 reveals features common to other collectin genes. Mamm Genome 1995: 6: 103-10.
62. Guo N, Mogues T, Weremowicz S, Morton CC, Sastry KN. The human ortholog of rhesus mannose-binding protein-A gene is an expressed pseudogene that localizes to chromosome 10. Mamm Genome 1998: 9: 246-9.
63. Seyfarth J, Garred P, Madsen HO. The 'involution' of mannose-binding lectin. Hum Mol Genet 2005: 14: 2859-69.
64. Allison AC. Protection afforded by sickle-cell trait against subtertian malareal infection. BMJ 1954: 4857: 290-4.
65. Santos IK, Costa CH, Krieger H et al. Mannan-binding lectin enhances susceptibility to visceral leishmaniasis. Infect Immun 2001: 69: 5212-5.
66. Garred P, Harboe M, Oettinger T, Koch C, Svejgaard A. Dual role of mannan-binding protein in infections: another case of heterosis? Eur J Immunogenet 1994: 21: 125-31.
67. Summerfield JA, Ryder S, Sumiya M et al. Mannose binding protein gene mutations associated with unusual and severe infections in adults. Lancet 1995: 345: 886-9.
68. Dahl M, Tybjaerg-Hansen A, Schnohr P, Nordestgaard BG. A population-based study of morbidity and mortality in mannose-binding lectin deficiency. J Exp Med 2004: 199: 1391-9.
69. Tacx AN, Groeneveld AB, Hart MH, Aarden LA, Hack CE. Mannan binding lectin in febrile adults: no correlation with microbial infection and complement activation. J Clin Pathol 2003: 56: 956-9.
70. Aittoniemi J, Baer M, Soppi E, Vesikari T, Miettinen A. Mannan binding lectin deficiency and concomitant immunodefects. Arch Dis Child 1998: 78: 245-8.
71. Turner MW, Super M, Levinsky RJ, Summerfield JA. The molecular basis of a common defect of opsonization. In: Chapel HM, Levinsky RJ, Webster ADB, eds. Progress in Immunodeficiency III, International Congress and Symposium Series. London and New York: Royal Society of Medicine Services Limited, 1991, 177-83.
72. Hamvas RM, Johnson M, Vlieger AM et al. Role for mannose binding lectin in the prevention of Mycoplasma infection. Infect Immun 2005: 73: 5238-40.
73. Rota PA, Oberste MS, Monroe SS et al. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 2003: 300: 1394-9.
74. Marra MA, Jones SJ, Astell CR et al. The genome sequence of the SARS-associated coronavirus. Science 2003: 300: 1399-404.
75. Ip WK, Chan KH, Law HK et al. Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection. J Infect Dis 2005: 191: 1697-704.
76. Zhang H, Zhou G, Zhi L et al. Association between mannose-binding lectin gene polymorphisms and susceptibility to severe acute respiratory syndrome coronavirus infection. J Infect Dis 2005: 192: 1355-61.
77. Yuen MF, Lau CS, Lau YL, Wong WM, Cheng CC, Lai CL. Mannose binding lectin gene mutations are associated with progression of liver disease in chronic hepatitis B infection. Hepatology 1999: 29: 1248-51.
78. Chong WP, To YF, Ip WK et al. Mannose-binding lectin in chronic hepatitis B virus infection. Hepatology 2005: 42: 1037-45.
79. Thio CL, Mosbruger T, Astemborski J et al. Mannose binding lectin genotypes influence recovery from hepatitis B virus infection. J Virol 2005: 79: 9192-6.
80. Matsushita M, Hijikata M, Ohta Y et al. Hepatitis C virus infection and mutations of mannose-binding lectin gene MBL. Arch Virol 1998: 143: 645-51.
81. Neth O, Hann I, Turner MW, Klein NJ. Deficiency of mannose-binding lectin and burden of infection in children with malignancy: a prospective study. Lancet 2001: 358: 614-8.
82. Peterslund NA, Koch C, Jensenius JC, Thiel S. Association between deficiency of mannose-binding lectin and severe infections after chemotherapy. Lancet 2001: 358: 637-8.
83. Bergmann OJ, Christiansen M, Laursen I et al. Low levels of mannose-binding lectin do not affect occurrence of severe infections or duration of fever in acute myeloid leukaemia during remission induction therapy. Eur J Haematol 2003: 70: 91-7.
84. Shi L, Takahashi K, Dundee J et al. Mannose-binding lectin-deficient mice are susceptible to infection with Staphylococcus aureus. J Exp Med 2004: 199: 1379-90.
85. Ezekowitz RA, Kuhlman M, Groopman JE, Byrn RA. A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus. J Exp Med 1989: 169: 185-96.
86. Ying H, Ji X, Hart ML et al. Interaction of mannose-binding lectin with HIV type 1 is sufficient for virus opsonization but not neutralization. AIDS Res Hum Retroviruses 2004: 20: 327-35.
87. Garred P, Madsen HO, Balslev U et al. Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-binding lectin. Lancet 1997: 349: 236-40.
88. Garred P, Richter C, Andersen AB et al. Mannan-binding lectin in the sub-Saharan HIV and tuberculosis epidemics. Scand J Immunol 1997: 46: 204-8.
89. Nielsen SL, Andersen PL, Koch C, Jensenius JC, Thiel S. The level of the serum opsonin, mannan-binding protein in HIV-1 antibody-positive patients. Clin Exp Immunol 1995: 100: 219-22.
90. Prohaszka Z, Thiel S, Ujhelyi E, Szlavik J, Banhegyi D, Fust G. Mannan-binding lectin serum concentrations in HIV-infected patients are influenced by the stage of disease. Immunol Lett 1997: 58: 171-5.
91. Boniotto M, Crovella S, Pirulli D et al. Polymorphisms in the MBL2 promoter correlated with risk of HIV-1 vertical transmission and AIDS progression. Genes Immun 2000: 1: 346-8.
92. Malik S, Arias M, Di Flumeri C, Garcia LF, Schurr E. Absence of association between mannose-binding lectin gene polymorphisms and HIV-1 infection in a Colombian population. Immunogenetics 2003: 55: 49-52.
93. McBride MO, Fischer PB, Sumiya M et al. Mannose-binding protein in HIV-seropositive patients does not contribute to disease progression or bacterial infections. Int J STD AIDS 1998: 9: 683-8.
94. Senaldi G, Davies ET, Mahalingam M et al. Circulating levels of mannose binding protein in human immunodeficiency virus infection. J Infect 1995: 31: 145-8.
95. Maas J, Roda Husman AM, Brouwer M et al. Presence of the variant mannose-binding lectin alleles associated with slower progression to AIDS. Amsterdam Cohort Study. AIDS 1998: 12: 2275-80.
96. Arai T, Tabona P, Summerfield JA. Human mannose-binding protein gene is regulated by interleukins, dexamethasone and heat shock. Q J Med 1993: 86: 575-82.
97. Heggelund L, Mollnes TE, Espevik T et al. Modulatory effect of mannose-binding lectin on cytokine responses: possible roles in HIV infection. Eur J Clin Invest 2005: 35: 765-70.
98. Hundt M, Heiken H, Schmidt RE. Low mannose-binding lectin serum concentrations in HIV long-term nonprogressors? AIDS Res Hum Retroviruses 2000: 16: 1927.
99. Amoroso A, Berrino M, Boniotto M et al. Polymorphism at codon 54 of mannose-binding protein gene influences AIDS progression but not HIV infection in exposed children. AIDS 1999: 13: 863-4.
100. Garred P, Pressler T, Madsen HO et al. Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis. J Clin Invest 1999: 104: 431-7.
101. Davies JC, Turner MW, Klein N. Impaired pulmonary status in cystic fibrosis adults with two mutated MBL-2 alleles. Eur Respir J 2004: 24: 798-804.
102. Garred P, Strom J, Quist L, Taaning E, Madsen HO. Association of mannose-binding lectin polymorphisms with sepsis and fatal outcome, in patients with systemic inflammatory response syndrome. J Infect Dis 2003: 188: 1394-403.
103. Fidler KJ, Wilson P, Davies JC, Turner MW, Peters MJ, Klein NJ. Increased incidence and severity of the systemic inflammatory response syndrome in patients deficient in mannose-binding lectin. Intensive Care Med 2004: 30: 1438-45.
104. Saevarsdottir S, Oskarsson OO, Aspelund T et al. Mannan binding lectin as an adjunct to risk assessment for myocardial infarction in individuals with enhanced risk. J Exp Med 2005: 201: 117-25.
105. Lee YH, Witte T, Momot T et al. The mannose-binding lectin gene polymorphisms and systemic lupus erythematosus: two case-control studies and a meta-analysis. Arthritis Rheum 2005: 52: 3966-74.
106. Davies EJ, Teh LS, Ordi-Ros J et al. A dysfunctional allele of the mannose binding protein gene associates with systemic lupus erythematosus in a Spanish population. J Rheumatol 1997: 24: 485-8.
107. Ohlenschlaeger T, Garred P, Madsen HO, Jacobsen S. Mannose-binding lectin variant alleles and the risk of arterial thrombosis in systemic lupus erythematosus. N Engl J Med 2004: 351: 260-7.
108. Garred P, Voss A, Madsen HO, Junker P. Association of mannose-binding lectin gene variation with disease severity and infections in a population-based cohort of systemic lupus erythematosus patients. Genes Immun 2001: 2: 442-50.
109. Takahashi R, Tsutsumi A, Ohtani K et al. Association of mannose binding lectin (MBL) gene polymorphism and serum MBL concentration with characteristics and progression of systemic lupus erythematosus. Ann Rheum Dis 2005: 64: 311-4.
110. Malhotra R, Wormald MR, Rudd PM, Fischer PB, Dwek RA, Sim RB. Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nat Med 1995: 1: 237-43.
111. Graudal NA, Homann C, Madsen HO et al. Mannan binding lectin in rheumatoid arthritis. A longitudinal study. J Rheumatol 1998: 25: 629-35.
112. Valdimarsson H, Stefansson M, Vikingsdottir T et al. Reconstitution of opsonizing activity by infusion of mannan-binding lectin (MBL) to MBL-deficient humans. Scand J Immunol 1998: 48: 116-23.
113. Valdimarsson H, Vikingsdottir T, Bang P et al. Human plasma-derived mannose-binding lectin: a phase I safety and pharmacokinetic study. Scand J Immunol 2004: 59: 97-102.
114. Petersen SV, Thiel S, Jensen L, Steffensen R, Jensenius JC. An assay for the mannan-binding lectin pathway of complement activation. J Immunol Methods 2001: 257: 107-16.
115. Seelen MA, Roos A, Wieslander J et al. Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA. J Immunol Methods 2005: 296: 187-98.
116. Stengaard-Pedersen K, Thiel S, Gadjeva M et al. Inherited deficiency of mannan-binding lectin-associated serine protease 2. N Engl J Med 2003: 349: 554-60.
117. Carlsson M, Sjoholm AG, Eriksson L et al. Deficiency of the mannan-binding lectin pathway of complement and poor outcome in cystic fibrosis: bacterial colonization may be decisive for a relationship. Clin Exp Immunol 2005: 139: 306-13.
118. Atkinson AP, Cedzynski M, Szemraj J et al. L-ficolin in children with recurrent respiratory infections. Clin Exp Immunol 2004: 138: 517-20.
119. Cedzynski M, Szemraj J, Swierzko AS et al. Mannan-binding lectin insufficiency in children with recurrent infections of the respiratory system. Clin Exp Immunol 2004: 136: 304-11.
120. Casanova JL, Abel L. Human mannose-binding lectin in immunity: friend, foe, or both? J Exp Med 2004: 199: 1295-9.
121. Kawasaki N, Kawasaki T, Yamashina I. Isolation and characterization of a mannan-binding protein from human serum. J Biochem (Tokyo) 1983: 94: 937-47.
122. Richardson VF, Larcher VF, Price JF. A common congenital immunodeficiency predisposing to infection and atopy in infancy. Arch Dis Child 1983: 58: 799-802.
123. Kawasaki N, Kawasaki T, Yamashina I. Mannan-binding protein and conglutinin in bovine serum. J Biochem (Tokyo) 1985: 98: 1309-20.
124. Turner MW, Seymour ND, Kazatchkine MD, Mowbray JF. Suboptimal C3b/C3bi deposition and defective yeast opsonization. I. Evidence for the absence of essential co-factor activity. Clin Exp Immunol 1985: 62: 427-34.
125. Oka S, Ikeda K, Kawasaki T, Yamashina I. Isolation and characterization of two distinct mannan-binding proteins from rat serum. Arch Biochem Biophys 1988: 260: 257-66.
126. Drickamer K. Two distinct classes of carbohydrate-recognition domains in animal lectins. J Biol Chem 1988: 263: 9557-60.
127. Kawasaki N, Kawasaki T, Yamashina I. A serum lectin (mannan-binding protein) has complement-dependent bactericidal activity. J Biochem (Tokyo) 1989: 106: 483-9.
128. Super M, Levinsky RJ, Turner MW. The level of mannan-binding protein regulates the binding of complement-derived opsonins to mannan and zymosan at low serum concentrations. Clin Exp Immunol 1990: 79: 144-50.
129. Sastry K, Zahedi K, Lelias JM, Whitehead AS, Ezekowitz RA. Molecular characterization of the mouse mannose-binding proteins. The mannose-binding protein A but not C is an acute phase reactant. J Immunol 1991: 147: 692-7.
130. Weis WI, Drickamer K, Hendrickson WA. Structure of a C-type mannose-binding protein complexed with an oligosaccharide. Nature 1992: 360: 127-34.
131. Matsushita M, Takahashi A, Hatsuse H, Kawakami M, Fujita T. Human mannose-binding protein is identical to a component of Ra-reactive factor. Biochem Biophys Res Commun 1992: 183: 645-51.
132. Summerfield JA, Sumiya M, Levin M, Turner MW. Association of mutations in mannose binding protein gene with childhood infection in consecutive hospital series. BMJ 1997: 314: 1229-32.
133. Matsushita M, Endo Y, Fujita T. Cutting edge: complementactivating complex of ficolin and mannose-binding lectin-associated serine protease. J Immunol 2000: 164: 2281-4.
134. Jack DL, Jarvis GA, Booth CL, Turner MW, Klein NJ. Mannose-binding lectin accelerates complement activation and increases serum killing of Neisseria meningitidis serogroup C. J Infect Dis 2001: 184: 836-45.
135. Matsushita M, Kuraya M, Hamasaki N, Tsujimura M, Shiraki H, Fujita T. Activation of the lectin complement pathway by H-ficolin (Hakata antigen). J Immunol 2002: 168: 3502-6.
136. Townsend R, Read RC, Turner MW, Klein NJ, Jack DL. Differential recognition of obligate anaerobic bacteria by human mannose-binding lectin. Clin Exp Immunol 2001: 124: 223-8.
137. Davies J, Neth O, Alton E, Klein N, Turner M. Differential binding of mannose-binding lectin to respiratory pathogens in cystic fibrosis. Lancet 2000: 355: 1885-6.
138. Swanson AF, Ezekowitz RA, Lee A, Kuo CC. Human mannose-binding protein inhibits infection of HeLa cells by Chlamydia trachomatis. Infect Immun 1998: 66: 1607-12.
139. van Emmerik LC, Kuijper EJ, Fijen CA, Dankert J, Thiel S. Binding of mannan-binding protein to various bacterial pathogens of meningitis. Clin Exp Immunol 1994: 97: 411-6.
140. Polotsky VY, Belisle JT, Mikusova K, Ezekowitz RA, Joiner KA. Interaction of human mannose-binding protein with Mycobacterium avium. J Infect Dis 1997: 175: 1159-68.
141. Saifuddin M, Hart ML, Gewurz H, Zhang Y, Spear GT. Interaction of mannose-binding lectin with primary isolates of human immunodeficiency virus type 1. J Gen Virol 2000: 81: 949-55.
142. Hart ML, Saifuddin M, Uemura K et al. High mannose glycans and sialic acid on gp120 regulate binding of mannose-binding lectin (MBL) to HIV type 1. AIDS Res Hum Retroviruses 2002: 18: 1311-7.
143. Ji X, Gewurz H, Spear GT. Mannose binding lectin (MBL) and HIV. Mol Immunol 2005: 42: 145-52.
144. Fischer PB, Ellermann-Eriksen S, Thiel S, Jensenius JC, Mogensen SC. Mannan-binding protein and bovine conglutinin mediate enhancement of herpes simplex virus type 2 infection in mice. Scand J Immunol 1994: 39: 439-45.
145. Gadjeva M, Paludan SR, Thiel S et al. Mannan-binding lectin modulates the response to HSV-2 infection. Clin Exp Immunol 2004: 138: 304-11.
146. Tabona P, Mellor A, Summerfield JA. Mannose binding protein is involved in first-line host defence: evidence from transgenic mice. Immunology 1995: 85: 153-9.
147. Schelenz S, Malhotra R, Sim RB, Holmskov U, Bancroft GJ. Binding of host collectins to the pathogenic yeast Cryptococcus neoformans: human surfactant protein D acts as an agglutinin for acapsular yeast cells. Infect Immun 1995: 63: 3360-6.
148. Kelly P, Jack DL, Naeem A et al. Mannose-binding lectin is a component of innate mucosal defense against Cryptosporidium parvum in AIDS. Gastroenterology 2000: 119: 1236-42.
149. Klabunde J, Uhlemann AC, Tebo AE et al. Recognition of plasmodium falciparum proteins by mannan-binding lectin, a component of the human innate immune system. Parasitol Res 2002: 88: 113-7.
150. Kahn SJ, Wleklinski M, Ezekowitz RA, Coder D, Aruffo A, Farr A. The major surface glycoprotein of Trypanosoma cruzi amastigotes are ligands of the human serum mannose-binding protein. Infect Immun 1996: 64: 2649-56.
151. Lozano F, Suarez B, Munoz A et al. Novel MASP2 variants detected among North African and Sub-Saharan individuals. Tissue Antigens 2005: 66: 131-5.
152. Lee SG, Yum JS, Moon HM et al. Analysis of mannose-binding lectin 2 (MBL2) genotype and the serum protein levels in the Korean population. Mol Immunol 2005: 42: 969-77.
153. Matsushita M, Hijikata M, Matsushita M, Ohta Y, Mishiro S. Association of mannose-binding lectin gene haplotype LXPA and LYPB with interferon-resistant hepatitis C virus infection in Japanese patients. J Hepatol 1998: 29: 695-700.